Engineered microparticles modulate arginine metabolism to repolarize tumor-associated macrophages for refractory colorectal cancer treatment

Jun Wang,Shenghe Deng,Denglong Cheng,Junnan Gu,Le Qin,Fuwei Mao,Yifan Xue,Zhenxin Jiang,Mian Chen,Falong Zou,Ning Huang,Yinghao Cao,Kailin Cai
DOI: https://doi.org/10.1186/s12967-024-05652-3
IF: 8.44
2024-10-09
Journal of Translational Medicine
Abstract:Arginase is abundantly expressed in colorectal cancer and disrupts arginine metabolism, promoting the formation of an immunosuppressive tumor microenvironment. This significant factor contributes to the insensitivity of colorectal cancer to immunotherapy. Tumor-associated macrophages (TAMs) are major immune cells in this environment, and aberrant arginine metabolism in tumor tissues induces TAM polarization toward M2-like macrophages. The natural compound piceatannol 3ʹ- O -glucoside inhibits arginase activity and activates nitric oxide synthase, thereby reducing M2-like macrophages while promoting M1-like macrophage polarization.
medicine, research & experimental
What problem does this paper attempt to address?